Pharmacologic and potential biologic interventions to restore bladder function after spinal cord injury

被引：19

作者：

Yoshimura, N

Smith, CP

Chancellor, MB

de Groat, WC

机构：

[1] Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15261 USA

[2] Univ Pittsburgh, Sch Med, Dept Urol, Pittsburgh, PA 15261 USA

来源：

CURRENT OPINION IN NEUROLOGY | 2000年 / 13卷 / 06期

关键词：

D O I：

10.1097/00019052-200012000-00011

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Spinal cord injury disrupts voluntary control of voiding and the normal reflex pathways that coordinate bladder and urethral sphincter function. The present review addresses studies in animals and humans that have evaluated various therapeutic approaches for normalizing lower urinary tract function after spinal cord injury. Curr Opin Neurol 13:677-681. (C) 2000 Lippincott Williams & Wilkins.

引用

收藏

页码：677 / 681

页数：5

相关论文

共 52 条

[21]

Gupta SK, 1999, J CLIN PHARMACOL, V39, P289

[22] Muscarinic receptor subtypes modulating smooth muscle contractility in the urinary bladder [J].

Hegde, SS ;

Eglen, RM .

LIFE SCIENCES, 1999, 64 (6-7) :419-428

[23]

Hohenfellner M, 2000, BJU Int, V85 Suppl 3, P10

[24] The role of oxybutynin in spinal cord injured patients with indwelling catheters [J].

Kim, YH ;

Bird, ET ;

Priebe, M ;

Boone, TB .

JOURNAL OF UROLOGY, 1997, 158 (06) :2083-2086

[25] Effects of intravesical capsaicin and resiniferatoxin on distension-induced bladder contraction in conscious rats with and without chronic spinal cord injury [J].

Komiyama, I ;

Igawa, Y ;

Ishizuka, O ;

Nishizawa, O ;

Andersson, KE .

JOURNAL OF UROLOGY, 1999, 161 (01) :314-319

[26] Neutralizing intraspinal nerve growth factor blocks autonomic dysreflexia caused by spinal cord injury [J].

Krenz, NR ;

Meakin, SO ;

Krassioukov, AV ;

Weaver, LC .

JOURNAL OF NEUROSCIENCE, 1999, 19 (17) :7405-7414

[27]

Kuno S., 1999, Society for Neuroscience Abstracts, V25, P1686

[28] Tolterodine in the treatment of overactive bladder:: Analysis of the pooled Phase II efficacy and safety data [J].

Larsson, G ;

Hallén, B ;

Nilvebrant, L .

UROLOGY, 1999, 53 (05) :990-998

[29] Clinical efficacy and safety of tolterodine compared to placebo in detrusor overactivity [J].

Millard, R ;

Tuttle, J ;

Moore, K ;

Susset, J ;

Clarke, B ;

Dwyer, P ;

Davis, BE .

JOURNAL OF UROLOGY, 1999, 161 (05) :1551-1555

[30]

Mitcheson H. D., 1999, Neurourology and Urodynamics, V18, P381

← 1 2 3 4 5 6 →